Bontempo Ohly Capital Management’s Boston Scientific BSX Stock Holding History

Bontempo Ohly Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,796	Closed	-$238K	–	34
2026 Q1	$238K	Hold	3,796	–	–	0.11%	32
2025 Q4	$362K	Hold	3,796	–	–	0.16%	30
2025 Q3	$371K	Hold	3,796	–	–	0.16%	30
2025 Q2	$408K	Hold	3,796	–	–	0.18%	30
2025 Q1	$383K	Hold	3,796	–	–	0.18%	30
2024 Q4	$339K	Hold	3,796	–	–	0.17%	31
2024 Q3	$318K	Hold	3,796	–	–	0.15%	33
2024 Q2	$292K	Hold	3,796	–	–	0.15%	32
2024 Q1	$260K	Hold	3,796	–	–	0.13%	32
2023 Q4	$219K	Hold	3,796	–	–	0.11%	36
2023 Q3	$200K	Sell	3,796 -3,796	-50%	-$199K	0.11%	35
2023 Q2	$411K	Hold	7,592	–	–	0.2%	35
2023 Q1	$380K	Buy	+7,592	New	+$358K	0.19%	34

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bontempo Ohly Capital Management's BSX Position: Q2 2026 in Review

Bontempo Ohly Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,796 shares — an estimated $238K sold.

Bontempo Ohly Capital Management first reported a position in BSX in Q1 2023 and held it in 13 quarters. The position peaked at $411K in Q2 2023. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Bontempo Ohly Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Bontempo Ohly Capital Management sold 3,796 Boston Scientific shares in Q2 2026, an estimated $238K.
Bontempo Ohly Capital Management first reported a position in Boston Scientific in Q1 2023 and held it in 13 quarters.
Bontempo Ohly Capital Management's Boston Scientific position peaked at $411K in Q2 2023.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bontempo Ohly Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.